Related Experiment Video
Updated: Jun 9, 2026

09:09
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Local antibiotic delivery with bovine cancellous chips
Christine S Lewis1, Jordan Katz, Maribel I Baker
1Biotechnology Research Group, RTI Biologics, Inc., 11621 Research Circle, Alachua, FL, USA. clewis@rtix.com
Journal of Biomaterials Applications
|September 8, 2010
Summary
This study shows a bone void filler can be loaded with gentamicin to fight infection for 14 days. The infused filler is safe for bone cells, offering a new option for treating osteomyelitis.
Area of Science:
- Orthopedics
- Biomaterials Science
- Infectious Diseases
Background:
- Osteomyelitis and infected bone defects are common in trauma.
- Current treatment involves systemic antibiotics and removable antibiotic beads, requiring a second surgery.
- There is a need for improved local antibiotic delivery methods.
Purpose of the Study:
- To investigate a common bone void filler's ability to be infused with an antibiotic.
- To assess the in vitro release of gentamicin from the bone void filler.
- To evaluate the effect of released gentamicin on osteoblast cell proliferation and function.
Main Methods:
- A xenograft bone void filler was loaded with gentamicin.
- Gentamicin release was measured in vitro over 14 days.
- Osteoblast cell proliferation and alkaline phosphatase activity were assessed.
Main Results:
- The bone void filler successfully loaded and released gentamicin for at least 14 days in vitro.
- Released gentamicin inhibited bacterial growth on the graft.
- The released gentamicin did not adversely affect osteoblast cell proliferation or alkaline phosphatase production.
Conclusions:
- The tested xenograft material can be infused with gentamicin for sustained local antibiotic delivery.
- This bone void filler demonstrates potential as a viable alternative to current antibiotic delivery methods in orthopedic applications.
- Further research may validate its use in treating osteomyelitis and infected bone defects.